Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bill Anderson
Pharma
Bayer weathers LOE for Xarelto with success of Kerendia, Nubeqa
Thanks to hefty sales increases from Kerendia and Nubeqa, Bayer’s pharma division weathered the loss of exclusivity in the U.S. of Xarelto in Q1.
Kevin Dunleavy
May 13, 2025 11:25am
Bayer CEO took pay cut in 2024 amid restructuring effort
Mar 7, 2025 11:14am
Bayer projects Xarelto's sales decline will gain steam in 2025
Mar 5, 2025 11:17am
Bayer's 'transition year' looms as Xarelto sales falter
Nov 12, 2024 3:03pm
After cutting 1,500 in Q1, Bayer laid off 1,700 more in Q2
Aug 6, 2024 9:58am
Bayer cut 1,500 roles in Q1 as new organization takes shape
May 14, 2024 9:49am
